Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (271-280 of 324) with videos related to

Pageof 33
Sort By:
Alimentary Pharmacology & Therapeutics|January 19, 2007
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemiaV Ratziu, P Giral, M Munteanu, et al.
Journal of Hepatology|August 1, 1996
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of BiologistsD Lebrec, N Giuily, A Hadengue, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1987
Reduction of the observed prevalence of so-called non-A non-B hepatitis using sensitive markers of HBV and herpes viruses infectionsT Poynard, J F Delfraissy, S Naveau, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|May 1, 1980
[New technics of insulin adminstration: experience of the Hotel-Dieu]G Slama, J C Klein, D Garrel, et al.
Hepatology (Baltimore, Md.)|October 1, 1992
Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trialO Ink, T Martin, T Poynard, et al.
Hepatology (Baltimore, Md.)|May 1, 1984
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final reportD Lebrec, T Poynard, J Bernuau, et al.
Gastroenterologie Clinique Et Biologique|July 31, 2009
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trialsT Poynard, J Massard, M Rudler, et al.
Scandinavian Journal of Gastroenterology|May 6, 2004
The burden cost of French patients suffering from irritable bowel syndromeC Le Pen, P Ruszniewski, A F Gaudin, et al.
Acta Gastro-Enterologica Belgica|January 29, 1999
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologieT Poynard, J Moussalli, V Ratziu, et al.
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Pageof 33

Showing results (271-280 of 324) with videos related to

Sort By:
Pageof 33
Alimentary Pharmacology & Therapeutics|January 19, 2007
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemiaV Ratziu, P Giral, M Munteanu, et al.
Journal of Hepatology|August 1, 1996
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of BiologistsD Lebrec, N Giuily, A Hadengue, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1987
Reduction of the observed prevalence of so-called non-A non-B hepatitis using sensitive markers of HBV and herpes viruses infectionsT Poynard, J F Delfraissy, S Naveau, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|May 1, 1980
[New technics of insulin adminstration: experience of the Hotel-Dieu]G Slama, J C Klein, D Garrel, et al.
Hepatology (Baltimore, Md.)|October 1, 1992
Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trialO Ink, T Martin, T Poynard, et al.
Hepatology (Baltimore, Md.)|May 1, 1984
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final reportD Lebrec, T Poynard, J Bernuau, et al.
Gastroenterologie Clinique Et Biologique|July 31, 2009
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trialsT Poynard, J Massard, M Rudler, et al.
Scandinavian Journal of Gastroenterology|May 6, 2004
The burden cost of French patients suffering from irritable bowel syndromeC Le Pen, P Ruszniewski, A F Gaudin, et al.
Acta Gastro-Enterologica Belgica|January 29, 1999
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologieT Poynard, J Moussalli, V Ratziu, et al.
Hepatology (Baltimore, Md.)|May 1, 1987
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleedingT Poynard, D Lebrec, P Hillon, et al.
Pageof 33